Literature DB >> 15991151

Brucella endocarditis: the importance of surgical timing after medical treatment (five cases).

Ibrahim Ozsöyler1, Levent Yilik, Sahin Bozok, Sibel El, Bilgin Emrecan, Serdar Biçeroğlu, Ali Gürbüz.   

Abstract

INTRODUCTION: Brucella endocarditis is a disease that is hard to treat medically and has a high mortality. Immediate surgery after medical treatment is very important because delaying surgery may lead to that are difficult to repair.
METHODS: Five patients who were admitted to our institution with a diagnosis of Brucella endocarditis were medically treated with doxycycline (200 mg/d), rifampin (600 mg/d), and ceftriaxone (2 g/d). Preoperative mean medical treatment time was 5.2 weeks (range, 4-6 weeks). The patients were taken for operation when their general status improved. We report in this study the results of these patients.
RESULTS: Three patients had aortic valve replacement whereas 2 had both aortic and mitral valve replacements. No mortality or morbidity was encountered in the patients. Mean postoperative hospitalization time was 15 days (range, 12-19 days). The patients were discharged with doxycycline (200 mg/d) and rifampin (600 mg/d) but without antipyretic medication. Postoperative antibiotherapy was continued up to a mean of 3.6 months (range, 2-6 months). Mean postoperative follow-up time was 15.8 months. None of the patients needed hospitalization in their follow-up time.
CONCLUSION: Adequate preoperative antibiotherapy, immediate surgery, and continuation of postoperative antibiotherapy according to clinical progress seem to be a convenient treatment strategy for Brucella endocarditis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15991151     DOI: 10.1016/j.pcad.2004.10.001

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  4 in total

1.  Brucella endocarditis in a non-endemic area presenting as pyrexia of unknown origin.

Authors:  Vivek Vilas Manade; Arjun Kakrani; Siddharth Narayan Gadage; Rabindra Misra
Journal:  BMJ Case Rep       Date:  2014-09-19

Review 2.  The current therapeutical strategies in human brucellosis.

Authors:  Mile Bosilkovski; Fariba Keramat; Jurica Arapović
Journal:  Infection       Date:  2021-03-01       Impact factor: 3.553

Review 3.  Medical versus medical and surgical treatment for brucella endocarditis.

Authors:  Maryam Keshtkar-Jahromi; Seyed-Mostafa Razavi; Sharareh Gholamin; Marzieh Keshtkar-Jahromi; Mian Hossain; Mohammad M Sajadi
Journal:  Ann Thorac Surg       Date:  2012-10-26       Impact factor: 4.330

4.  Brucella endocarditis as a late onset complication of brucellosis.

Authors:  Panagiotis Andriopoulos; Christos Antoniou; Panagiota Manolakou; Athanassios Vasilopoulos; George Assimakopoulos; Maria Tsironi
Journal:  Case Rep Infect Dis       Date:  2015-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.